0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Bradykinin Receptor Antagonists Market Research Report 2026
Published Date: 2026-02-10
|
Report Code: QYRE-Auto-14O18470
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Bradykinin Receptor Antagonists Market Research Report 2024
BUY CHAPTERS

Global Bradykinin Receptor Antagonists Market Research Report 2026

Code: QYRE-Auto-14O18470
Report
2026-02-10
Pages:115
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Bradykinin Receptor Antagonists Market

The global Bradykinin Receptor Antagonists market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Bradykinin Receptor Antagonists competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Bradykinin receptor antagonists are compounds that block the activity of bradykinin receptors, specifically the B1 and B2 receptors. By inhibiting these receptors, bradykinin receptor antagonists prevent the binding of bradykinin, thus reducing its effects such as vasodilation, increased vascular permeability, and pain signaling. These antagonists are used in the treatment of conditions like hereditary angioedema, chronic pain, and inflammatory diseases.
The North American market for Bradykinin Receptor Antagonists is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Bradykinin Receptor Antagonists is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Bradykinin Receptor Antagonists include Takeda Pharmaceuticals, Eugia Pharma Specialities, Glenmark Pharmaceuticals, Sandoz, Cipla, Fresenius Kabi, Jiangsu Hengrui Pharmaceuticals, Chengdu Shengnuo Biology Pharmacy, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Bradykinin Receptor Antagonists market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Bradykinin Receptor Antagonists. The Bradykinin Receptor Antagonists market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Bradykinin Receptor Antagonists market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Bradykinin Receptor Antagonists manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Bradykinin Receptor Antagonists Market Report

Report Metric Details
Report Name Bradykinin Receptor Antagonists Market
Segment by Type
  • Icatibant
  • Other
by Application
  • Hospital and Clinic
  • Pharmacy
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Takeda Pharmaceuticals, Eugia Pharma Specialities, Glenmark Pharmaceuticals, Sandoz, Cipla, Fresenius Kabi, Jiangsu Hengrui Pharmaceuticals, Chengdu Shengnuo Biology Pharmacy
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Bradykinin Receptor Antagonists manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Bradykinin Receptor Antagonists sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Bradykinin Receptor Antagonists Market report?

Ans: The main players in the Bradykinin Receptor Antagonists Market are Takeda Pharmaceuticals, Eugia Pharma Specialities, Glenmark Pharmaceuticals, Sandoz, Cipla, Fresenius Kabi, Jiangsu Hengrui Pharmaceuticals, Chengdu Shengnuo Biology Pharmacy

What are the Application segmentation covered in the Bradykinin Receptor Antagonists Market report?

Ans: The Applications covered in the Bradykinin Receptor Antagonists Market report are Hospital and Clinic, Pharmacy, Other

What are the Type segmentation covered in the Bradykinin Receptor Antagonists Market report?

Ans: The Types covered in the Bradykinin Receptor Antagonists Market report are Icatibant, Other

1 Bradykinin Receptor Antagonists Market Overview
1.1 Product Definition
1.2 Bradykinin Receptor Antagonists by Type
1.2.1 Global Bradykinin Receptor Antagonists Market Value by Type: 2025 vs 2032
1.2.2 Icatibant
1.2.3 Other
1.3 Bradykinin Receptor Antagonists by Application
1.3.1 Global Bradykinin Receptor Antagonists Market Value by Application: 2025 vs 2032
1.3.2 Hospital and Clinic
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Bradykinin Receptor Antagonists Market Size Estimates and Forecasts
1.4.1 Global Bradykinin Receptor Antagonists Revenue 2021–2032
1.4.2 Global Bradykinin Receptor Antagonists Sales 2021–2032
1.4.3 Global Bradykinin Receptor Antagonists Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Bradykinin Receptor Antagonists Market Competition by Manufacturers
2.1 Global Bradykinin Receptor Antagonists Sales Market Share by Manufacturers (2021–2026)
2.2 Global Bradykinin Receptor Antagonists Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Bradykinin Receptor Antagonists Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Bradykinin Receptor Antagonists, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Bradykinin Receptor Antagonists, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Bradykinin Receptor Antagonists, Product Types and Applications
2.7 Global Key Manufacturers of Bradykinin Receptor Antagonists, Date of Entry into the Industry
2.8 Global Bradykinin Receptor Antagonists Market Competitive Situation and Trends
2.8.1 Global Bradykinin Receptor Antagonists Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Bradykinin Receptor Antagonists Players Market Share by Revenue
2.8.3 Global Bradykinin Receptor Antagonists Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Bradykinin Receptor Antagonists Market Scenario by Region
3.1 Global Bradykinin Receptor Antagonists Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Bradykinin Receptor Antagonists Sales by Region: 2021–2032
3.2.1 Global Bradykinin Receptor Antagonists Sales by Region: 2021–2026
3.2.2 Global Bradykinin Receptor Antagonists Sales by Region: 2027–2032
3.3 Global Bradykinin Receptor Antagonists Revenue by Region: 2021–2032
3.3.1 Global Bradykinin Receptor Antagonists Revenue by Region: 2021–2026
3.3.2 Global Bradykinin Receptor Antagonists Revenue by Region: 2027–2032
3.4 North America Bradykinin Receptor Antagonists Market Facts & Figures by Country
3.4.1 North America Bradykinin Receptor Antagonists Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Bradykinin Receptor Antagonists Sales by Country (2021–2032)
3.4.3 North America Bradykinin Receptor Antagonists Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Bradykinin Receptor Antagonists Market Facts & Figures by Country
3.5.1 Europe Bradykinin Receptor Antagonists Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Bradykinin Receptor Antagonists Sales by Country (2021–2032)
3.5.3 Europe Bradykinin Receptor Antagonists Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bradykinin Receptor Antagonists Market Facts & Figures by Region
3.6.1 Asia Pacific Bradykinin Receptor Antagonists Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Bradykinin Receptor Antagonists Sales by Region (2021–2032)
3.6.3 Asia Pacific Bradykinin Receptor Antagonists Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Bradykinin Receptor Antagonists Market Facts & Figures by Country
3.7.1 Latin America Bradykinin Receptor Antagonists Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Bradykinin Receptor Antagonists Sales by Country (2021–2032)
3.7.3 Latin America Bradykinin Receptor Antagonists Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Bradykinin Receptor Antagonists Market Facts & Figures by Country
3.8.1 Middle East and Africa Bradykinin Receptor Antagonists Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Bradykinin Receptor Antagonists Sales by Country (2021–2032)
3.8.3 Middle East and Africa Bradykinin Receptor Antagonists Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bradykinin Receptor Antagonists Sales by Type (2021–2032)
4.1.1 Global Bradykinin Receptor Antagonists Sales by Type (2021–2026)
4.1.2 Global Bradykinin Receptor Antagonists Sales by Type (2027–2032)
4.1.3 Global Bradykinin Receptor Antagonists Sales Market Share by Type (2021–2032)
4.2 Global Bradykinin Receptor Antagonists Revenue by Type (2021–2032)
4.2.1 Global Bradykinin Receptor Antagonists Revenue by Type (2021–2026)
4.2.2 Global Bradykinin Receptor Antagonists Revenue by Type (2027–2032)
4.2.3 Global Bradykinin Receptor Antagonists Revenue Market Share by Type (2021–2032)
4.3 Global Bradykinin Receptor Antagonists Price by Type (2021–2032)
5 Segment by Application
5.1 Global Bradykinin Receptor Antagonists Sales by Application (2021–2032)
5.1.1 Global Bradykinin Receptor Antagonists Sales by Application (2021–2026)
5.1.2 Global Bradykinin Receptor Antagonists Sales by Application (2027–2032)
5.1.3 Global Bradykinin Receptor Antagonists Sales Market Share by Application (2021–2032)
5.2 Global Bradykinin Receptor Antagonists Revenue by Application (2021–2032)
5.2.1 Global Bradykinin Receptor Antagonists Revenue by Application (2021–2026)
5.2.2 Global Bradykinin Receptor Antagonists Revenue by Application (2027–2032)
5.2.3 Global Bradykinin Receptor Antagonists Revenue Market Share by Application (2021–2032)
5.3 Global Bradykinin Receptor Antagonists Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Takeda Pharmaceuticals
6.1.1 Takeda Pharmaceuticals Company Information
6.1.2 Takeda Pharmaceuticals Description and Business Overview
6.1.3 Takeda Pharmaceuticals Bradykinin Receptor Antagonists Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Takeda Pharmaceuticals Bradykinin Receptor Antagonists Product Portfolio
6.1.5 Takeda Pharmaceuticals Recent Developments/Updates
6.2 Eugia Pharma Specialities
6.2.1 Eugia Pharma Specialities Company Information
6.2.2 Eugia Pharma Specialities Description and Business Overview
6.2.3 Eugia Pharma Specialities Bradykinin Receptor Antagonists Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Eugia Pharma Specialities Bradykinin Receptor Antagonists Product Portfolio
6.2.5 Eugia Pharma Specialities Recent Developments/Updates
6.3 Glenmark Pharmaceuticals
6.3.1 Glenmark Pharmaceuticals Company Information
6.3.2 Glenmark Pharmaceuticals Description and Business Overview
6.3.3 Glenmark Pharmaceuticals Bradykinin Receptor Antagonists Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Glenmark Pharmaceuticals Bradykinin Receptor Antagonists Product Portfolio
6.3.5 Glenmark Pharmaceuticals Recent Developments/Updates
6.4 Sandoz
6.4.1 Sandoz Company Information
6.4.2 Sandoz Description and Business Overview
6.4.3 Sandoz Bradykinin Receptor Antagonists Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Sandoz Bradykinin Receptor Antagonists Product Portfolio
6.4.5 Sandoz Recent Developments/Updates
6.5 Cipla
6.5.1 Cipla Company Information
6.5.2 Cipla Description and Business Overview
6.5.3 Cipla Bradykinin Receptor Antagonists Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Cipla Bradykinin Receptor Antagonists Product Portfolio
6.5.5 Cipla Recent Developments/Updates
6.6 Fresenius Kabi
6.6.1 Fresenius Kabi Company Information
6.6.2 Fresenius Kabi Description and Business Overview
6.6.3 Fresenius Kabi Bradykinin Receptor Antagonists Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Fresenius Kabi Bradykinin Receptor Antagonists Product Portfolio
6.6.5 Fresenius Kabi Recent Developments/Updates
6.7 Jiangsu Hengrui Pharmaceuticals
6.7.1 Jiangsu Hengrui Pharmaceuticals Company Information
6.7.2 Jiangsu Hengrui Pharmaceuticals Description and Business Overview
6.7.3 Jiangsu Hengrui Pharmaceuticals Bradykinin Receptor Antagonists Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Jiangsu Hengrui Pharmaceuticals Bradykinin Receptor Antagonists Product Portfolio
6.7.5 Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
6.8 Chengdu Shengnuo Biology Pharmacy
6.8.1 Chengdu Shengnuo Biology Pharmacy Company Information
6.8.2 Chengdu Shengnuo Biology Pharmacy Description and Business Overview
6.8.3 Chengdu Shengnuo Biology Pharmacy Bradykinin Receptor Antagonists Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Chengdu Shengnuo Biology Pharmacy Bradykinin Receptor Antagonists Product Portfolio
6.8.5 Chengdu Shengnuo Biology Pharmacy Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bradykinin Receptor Antagonists Industry Chain Analysis
7.2 Bradykinin Receptor Antagonists Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bradykinin Receptor Antagonists Production Mode & Process Analysis
7.4 Bradykinin Receptor Antagonists Sales and Marketing
7.4.1 Bradykinin Receptor Antagonists Sales Channels
7.4.2 Bradykinin Receptor Antagonists Distributors
7.5 Bradykinin Receptor Antagonists Customer Analysis
8 Bradykinin Receptor Antagonists Market Dynamics
8.1 Bradykinin Receptor Antagonists Industry Trends
8.2 Bradykinin Receptor Antagonists Market Drivers
8.3 Bradykinin Receptor Antagonists Market Challenges
8.4 Bradykinin Receptor Antagonists Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Bradykinin Receptor Antagonists Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Bradykinin Receptor Antagonists Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Bradykinin Receptor Antagonists Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Bradykinin Receptor Antagonists Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Bradykinin Receptor Antagonists Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Bradykinin Receptor Antagonists Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Bradykinin Receptor Antagonists Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Bradykinin Receptor Antagonists Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Bradykinin Receptor Antagonists, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Bradykinin Receptor Antagonists, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Bradykinin Receptor Antagonists, Product Types and Applications
 Table 12. Global Key Manufacturers of Bradykinin Receptor Antagonists, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Bradykinin Receptor Antagonists Companies by Tier (Tier 1, Tier 2, Tier 3), based on Bradykinin Receptor Antagonists Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Bradykinin Receptor Antagonists Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Bradykinin Receptor Antagonists Sales by Region (K Units), 2021–2026
 Table 18. Global Bradykinin Receptor Antagonists Sales Market Share by Region (2021–2026)
 Table 19. Global Bradykinin Receptor Antagonists Sales by Region (K Units), 2027–2032
 Table 20. Global Bradykinin Receptor Antagonists Sales Market Share by Region (2027–2032)
 Table 21. Global Bradykinin Receptor Antagonists Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Bradykinin Receptor Antagonists Revenue Market Share by Region (2021–2026)
 Table 23. Global Bradykinin Receptor Antagonists Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Bradykinin Receptor Antagonists Revenue Market Share by Region (2027–2032)
 Table 25. North America Bradykinin Receptor Antagonists Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Bradykinin Receptor Antagonists Sales by Country (K Units), 2021–2026
 Table 27. North America Bradykinin Receptor Antagonists Sales by Country (K Units), 2027–2032
 Table 28. North America Bradykinin Receptor Antagonists Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Bradykinin Receptor Antagonists Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Bradykinin Receptor Antagonists Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Bradykinin Receptor Antagonists Sales by Country (K Units), 2021–2026
 Table 32. Europe Bradykinin Receptor Antagonists Sales by Country (K Units), 2027–2032
 Table 33. Europe Bradykinin Receptor Antagonists Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Bradykinin Receptor Antagonists Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Bradykinin Receptor Antagonists Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Bradykinin Receptor Antagonists Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Bradykinin Receptor Antagonists Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Bradykinin Receptor Antagonists Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Bradykinin Receptor Antagonists Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Bradykinin Receptor Antagonists Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Bradykinin Receptor Antagonists Sales by Country (K Units), 2021–2026
 Table 42. Latin America Bradykinin Receptor Antagonists Sales by Country (K Units), 2027–2032
 Table 43. Latin America Bradykinin Receptor Antagonists Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Bradykinin Receptor Antagonists Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Bradykinin Receptor Antagonists Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Bradykinin Receptor Antagonists Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Bradykinin Receptor Antagonists Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Bradykinin Receptor Antagonists Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Bradykinin Receptor Antagonists Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Bradykinin Receptor Antagonists Sales (K Units) by Type (2021–2026)
 Table 51. Global Bradykinin Receptor Antagonists Sales (K Units) by Type (2027–2032)
 Table 52. Global Bradykinin Receptor Antagonists Sales Market Share by Type (2021–2026)
 Table 53. Global Bradykinin Receptor Antagonists Sales Market Share by Type (2027–2032)
 Table 54. Global Bradykinin Receptor Antagonists Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Bradykinin Receptor Antagonists Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Bradykinin Receptor Antagonists Revenue Market Share by Type (2021–2026)
 Table 57. Global Bradykinin Receptor Antagonists Revenue Market Share by Type (2027–2032)
 Table 58. Global Bradykinin Receptor Antagonists Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Bradykinin Receptor Antagonists Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Bradykinin Receptor Antagonists Sales (K Units) by Application (2021–2026)
 Table 61. Global Bradykinin Receptor Antagonists Sales (K Units) by Application (2027–2032)
 Table 62. Global Bradykinin Receptor Antagonists Sales Market Share by Application (2021–2026)
 Table 63. Global Bradykinin Receptor Antagonists Sales Market Share by Application (2027–2032)
 Table 64. Global Bradykinin Receptor Antagonists Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Bradykinin Receptor Antagonists Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Bradykinin Receptor Antagonists Revenue Market Share by Application (2021–2026)
 Table 67. Global Bradykinin Receptor Antagonists Revenue Market Share by Application (2027–2032)
 Table 68. Global Bradykinin Receptor Antagonists Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Bradykinin Receptor Antagonists Price (US$/Unit) by Application (2027–2032)
 Table 70. Takeda Pharmaceuticals Company Information
 Table 71. Takeda Pharmaceuticals Description and Business Overview
 Table 72. Takeda Pharmaceuticals Bradykinin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Takeda Pharmaceuticals Bradykinin Receptor Antagonists Product
 Table 74. Takeda Pharmaceuticals Recent Developments/Updates
 Table 75. Eugia Pharma Specialities Company Information
 Table 76. Eugia Pharma Specialities Description and Business Overview
 Table 77. Eugia Pharma Specialities Bradykinin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Eugia Pharma Specialities Bradykinin Receptor Antagonists Product
 Table 79. Eugia Pharma Specialities Recent Developments/Updates
 Table 80. Glenmark Pharmaceuticals Company Information
 Table 81. Glenmark Pharmaceuticals Description and Business Overview
 Table 82. Glenmark Pharmaceuticals Bradykinin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Glenmark Pharmaceuticals Bradykinin Receptor Antagonists Product
 Table 84. Glenmark Pharmaceuticals Recent Developments/Updates
 Table 85. Sandoz Company Information
 Table 86. Sandoz Description and Business Overview
 Table 87. Sandoz Bradykinin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Sandoz Bradykinin Receptor Antagonists Product
 Table 89. Sandoz Recent Developments/Updates
 Table 90. Cipla Company Information
 Table 91. Cipla Description and Business Overview
 Table 92. Cipla Bradykinin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Cipla Bradykinin Receptor Antagonists Product
 Table 94. Cipla Recent Developments/Updates
 Table 95. Fresenius Kabi Company Information
 Table 96. Fresenius Kabi Description and Business Overview
 Table 97. Fresenius Kabi Bradykinin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Fresenius Kabi Bradykinin Receptor Antagonists Product
 Table 99. Fresenius Kabi Recent Developments/Updates
 Table 100. Jiangsu Hengrui Pharmaceuticals Company Information
 Table 101. Jiangsu Hengrui Pharmaceuticals Description and Business Overview
 Table 102. Jiangsu Hengrui Pharmaceuticals Bradykinin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Jiangsu Hengrui Pharmaceuticals Bradykinin Receptor Antagonists Product
 Table 104. Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
 Table 105. Chengdu Shengnuo Biology Pharmacy Company Information
 Table 106. Chengdu Shengnuo Biology Pharmacy Description and Business Overview
 Table 107. Chengdu Shengnuo Biology Pharmacy Bradykinin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Chengdu Shengnuo Biology Pharmacy Bradykinin Receptor Antagonists Product
 Table 109. Chengdu Shengnuo Biology Pharmacy Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Bradykinin Receptor Antagonists Distributors List
 Table 113. Bradykinin Receptor Antagonists Customers List
 Table 114. Bradykinin Receptor Antagonists Market Trends
 Table 115. Bradykinin Receptor Antagonists Market Drivers
 Table 116. Bradykinin Receptor Antagonists Market Challenges
 Table 117. Bradykinin Receptor Antagonists Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Bradykinin Receptor Antagonists
 Figure 2. Global Bradykinin Receptor Antagonists Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Bradykinin Receptor Antagonists Market Share by Type: 2025 & 2032
 Figure 4. Icatibant Product Picture
 Figure 5. Other Product Picture
 Figure 6. Global Bradykinin Receptor Antagonists Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Bradykinin Receptor Antagonists Market Share by Application: 2025 & 2032
 Figure 8. Hospital and Clinic
 Figure 9. Pharmacy
 Figure 10. Other
 Figure 11. Global Bradykinin Receptor Antagonists Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Bradykinin Receptor Antagonists Market Size (US$ Million), 2021–2032
 Figure 13. Global Bradykinin Receptor Antagonists Sales (K Units), 2021–2032
 Figure 14. Global Bradykinin Receptor Antagonists Average Price (US$/Unit), 2021–2032
 Figure 15. Bradykinin Receptor Antagonists Report Years Considered
 Figure 16. Bradykinin Receptor Antagonists Sales Share by Manufacturers in 2025
 Figure 17. Global Bradykinin Receptor Antagonists Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Bradykinin Receptor Antagonists Players: Market Share by Revenue in Bradykinin Receptor Antagonists in 2025
 Figure 19. Bradykinin Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Bradykinin Receptor Antagonists Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Bradykinin Receptor Antagonists Sales Market Share by Country (2021–2032)
 Figure 22. North America Bradykinin Receptor Antagonists Revenue Market Share by Country (2021–2032)
 Figure 23. United States Bradykinin Receptor Antagonists Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Bradykinin Receptor Antagonists Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Bradykinin Receptor Antagonists Sales Market Share by Country (2021–2032)
 Figure 26. Europe Bradykinin Receptor Antagonists Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Bradykinin Receptor Antagonists Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Bradykinin Receptor Antagonists Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Bradykinin Receptor Antagonists Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Bradykinin Receptor Antagonists Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Bradykinin Receptor Antagonists Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Bradykinin Receptor Antagonists Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Bradykinin Receptor Antagonists Revenue Market Share by Region (2021–2032)
 Figure 34. China Bradykinin Receptor Antagonists Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Bradykinin Receptor Antagonists Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Bradykinin Receptor Antagonists Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Bradykinin Receptor Antagonists Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Bradykinin Receptor Antagonists Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan Bradykinin Receptor Antagonists Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Southeast Asia Bradykinin Receptor Antagonists Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Latin America Bradykinin Receptor Antagonists Sales Market Share by Country (2021–2032)
 Figure 42. Latin America Bradykinin Receptor Antagonists Revenue Market Share by Country (2021–2032)
 Figure 43. Mexico Bradykinin Receptor Antagonists Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Brazil Bradykinin Receptor Antagonists Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Argentina Bradykinin Receptor Antagonists Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Colombia Bradykinin Receptor Antagonists Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Middle East and Africa Bradykinin Receptor Antagonists Sales Market Share by Country (2021–2032)
 Figure 48. Middle East and Africa Bradykinin Receptor Antagonists Revenue Market Share by Country (2021–2032)
 Figure 49. Turkey Bradykinin Receptor Antagonists Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Saudi Arabia Bradykinin Receptor Antagonists Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. UAE Bradykinin Receptor Antagonists Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Global Sales Market Share of Bradykinin Receptor Antagonists by Type (2021–2032)
 Figure 53. Global Revenue Market Share of Bradykinin Receptor Antagonists by Type (2021–2032)
 Figure 54. Global Bradykinin Receptor Antagonists Price (US$/Unit) by Type (2021–2032)
 Figure 55. Global Sales Market Share of Bradykinin Receptor Antagonists by Application (2021–2032)
 Figure 56. Global Revenue Market Share of Bradykinin Receptor Antagonists by Application (2021–2032)
 Figure 57. Global Bradykinin Receptor Antagonists Price (US$/Unit) by Application (2021–2032)
 Figure 58. Bradykinin Receptor Antagonists Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools